Comparison of <sup>11</sup>C-Methionine and <sup>18</sup>F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 27609791.
- Also identified by DOI 10.2967/jnumed.116.178640.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Methionine transport across plasma membranes occurs via the large amino acid transporter, which is overexpressed in malignant cells, leading to tracer accumulation within tumors. We investigated the uptake of <sup>11</sup>C-methionine (<sup>11</sup>C-MET) in children and young adults with Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL) and compared the biodistribution of <sup>11</sup>C-MET PET/CT with that of <sup>18</sup>F-FDG PET/CT. <b>Methods:</b> Conducted under an investigational new drug authorization, we prospectively enrolled patients with newly diagnosed HL (<i>n</i> = 19) and NHL (<i>n</i> = 2) onto the Institutional Review Board-approved investigation of <sup>11</sup>C-MET PET/CT. After a minimum 4-h fast, patients received 740 MBq/1.7 m<sup>2</sup> (maximum, 740 MBq [20 mCi/1.7 m<sup>2</sup>; maximum, 20 mCi]) of <sup>11</sup>C-methionine intravenously. PET/CT was performed 5 min after injection from the vertex to thighs at 3 min per bed position. In a separate session, patients received 5.5 MBq/kg (maximum, 485 MBq [0.15 mCi/kg; maximum, 12 mCi]) of <sup>18</sup>F-FDG with imaging initiated approximately 1 h after radiopharmaceutical administration. All studies were reviewed by consensus of 2 senior imaging specialists. The presence of metabolic activity on baseline studies was compared among 17 nodal groups. <b>Results:</b> Eighteen patients (11 male; median age, 15.2 y; age range, 9.5-22.6 y) comprised the study cohort. All had paired <sup>11</sup>C-MET PET/CT and <sup>18</sup>F-FDG PET/CT studies at diagnosis. At baseline, 3 nodal groups demonstrating discordant metabolic activity by both <sup>18</sup>F-FDG PET/CT and <sup>11</sup>C-MET PET/CT were Waldeyer's ring, paraaortic region, and the liver. All others were found to have concordant metabolic activity. Normal intense <sup>11</sup>C-MET uptake in the pancreas and liver reduced sensitivity for disease detection in these regions. At follow-up, 14 of 15 study pairs had concordant results. <b>Conclusion:</b><sup>11</sup>C-MET uptake is elevated in most regions involved with lymphoma at diagnosis and follow-up. Its utility in the abdomen is limited by uptake in normal structures.
Medical subject headings
- Fluorodeoxyglucose F18
- Lymphoma
- Methionine
- Positron Emission Tomography Computed Tomography